AnaptysBio, Inc. (ANAB) vs Generate Biomedicines, Inc. (GENB)
- AnaptysBio, Inc. ANAB 45.61 −0.26%
- Generate Biomedicines, Inc. GENB 9.83 −6.29%
AnaptysBio, Inc. and Generate Biomedicines, Inc. are both Biotechnology companies. AnaptysBio, Inc. and Generate Biomedicines, Inc. are of similar size ($1.4B and $1.3B). Generate Biomedicines, Inc. has negative trailing earnings, so its P/E is not meaningful; AnaptysBio, Inc. trades at 73.6×. AnaptysBio, Inc. has the higher net margin (6.54% vs −1,381.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, AnaptysBio, Inc. leads on 11 and Generate Biomedicines, Inc. on 3.
Valuation
Profitability
| Metric | ANAB | GENB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | 36.14% | (1,382.04%) | 0.00% |
| Net margin | 6.54% | (1,381.76%) | 0.00% |
| Free cash flow margin | 0.00% | (1,199.36%) | 0.00% |
| Return on equity | (365.73%) | 1,091.11% | (50.72%) |
| Return on assets | 4.76% | (56.30%) | (45.56%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack